Search Within

Howard Scher

Formats
  1. Journal Article (626)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (7)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1133)
  2. Genitourinary Oncology Service (1133)
  3. Solid Tumor Oncology Division (1133)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Department of Pathology and Laboratory Medicine (241)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (112)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Androgen deprivation for minimal metastatic disease: Threshold for achieving undetectable prostate-specific antigen
    Journal Article

    Beekman, K.; Morris, M.; Slovin, S.; Heller, G.; Wilton, A.; Bianco, F.; Scardino, P. T.; Scher, H. I.
    Urology (2005)

    Fulltext@MSK | Save
  • P27 deficiency accelerates progression of prostate cancer initiated by SV40 large T antigen
    Meeting Abstract

    Shaffer, D. R.; Ishiwata, R.; Olgac, S.; Scher, H. I.; Koff, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Development of a yeast based system to study the unique properties of mutant androgen receptors which may play a role in prostate cancer progression
    Meeting Abstract

    Robzyk, K.; Oen, H.; Butler, L.; Tilley, W.; Scher, H.; Rosen, N.; Caplan, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygaidanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Valentin, G.; Delacruz, A.; Ye, Q.; Schwartz, L.; Larson, S.; Rosen, N.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Hormonal induction followed by rapid hormonal cycling for prostate cancer (PC): The MEN's Cycle
    Meeting Abstract

    Nordquist, L.; Sauter, N.; Morris, M.; Smaletz, O.; Konopelski, K.; Delacruz, A.; Heller, G.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Multi-institutional trial of the epothilone B analogue BMS-247550 with or without estramustine phosphate (EMP) in patients with progressive castratemetastatic prostate cancer (PCMPC): Updated results
    Meeting Abstract

    Kelly, W. K.; Galsky, M. D.; Small, E. J.; Oh, W.; Chen, I.; Smith, D.; Martone, L.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine: Preliminary findings of a phase I safety/immunogenicity trial
    Meeting Abstract

    Gardner, J. P.; Slovin, S. F.; Morrissey, D. M.; Donovan, G. P.; Surowitz, K. G.; Olson, W. C.; Scher, H. I.; Israel, R. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • What is the probability of a positive bone scan (+BS) in patients with a rising PSA after radical prostatectomy (RP): A new nomogram
    Meeting Abstract

    Dotan, Z. A.; Kattan, M. W.; Bianco, F. J.; Rabbani, F.; Eastham, J. A.; Scher, H. I.; Chen, H. N.; Schoder, H.; Hricak, H.; Scardino, P. T.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Predicting time to metastatic progression from biochemical recurrence after radical prostatectomy
    Meeting Abstract

    Dotan, Z. A.; Bianco, F. J.; Scardino, P. T.; Eastham, J. A.; Fearn, P.; Scher, H. I.; Kattan, M. W.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Duration of response to androgen deprivation therapy and survival after subsequent biochemical relapse in men initially treated with radical prostatectomy
    Meeting Abstract

    Bianco, F. J.; Dotan, Z. A.; Kattan, M. W.; Fearn, P. A.; Scher, H. I.; Eastham, J. A.; Scardino, P. T.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save